PHS
CVRX icon

PFM Health Sciences’s CVRx CVRX Stock Holding History

PFM Health Sciences’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Buy
+369,572
New +$2.39M 0.16% 92

Other funds holding CVRX

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PFM Health Sciences's CVRX Position: Q2 2026 in Review

PFM Health Sciences opened a new position in CVRx (CVRX) in Q2 2026: 369,572 shares worth $1.9M. The stake represents 0.16% of the portfolio and ranks #92 among its holdings.

88 funds tracked by Wall St. Rank hold CVRX as of Q2 2026.

  • PFM Health Sciences held 369,572 shares of CVRx worth $1.9M as of Q2 2026.
  • CVRx was a new PFM Health Sciences position in Q2 2026.
  • CVRx made up 0.16% of PFM Health Sciences's portfolio in Q2 2026, its #92 holding.
  • 88 funds tracked by Wall St. Rank held CVRx as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.